Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Brainsway Ltd (BRIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6610
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It offers deep TMS that used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway conducts various clinical research programs. The company also operates online portals for patients, physicians and researchers, among others. It partners with various institutions and researchers in clinical trials covering various neuropsychiatric, neuroscience applications, and others. The company operates in Israel. Brainsway is headquartered in Jerusalem, Israel.

Brainsway Ltd (BRIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Ltd, Medical Equipment, Deal Details 10
Private Equity 10
Brainsway Raises USD8.5 Million in Financing 10
Partnerships 11
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Equity Offering 14
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd – Key Competitors 17
Brainsway Ltd – Key Employees 18
Brainsway Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 27, 2018: Brainsway announces financial results for second quarter of 2018 20
May 29, 2018: Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update 22
Mar 19, 2018: Brainsway Announces Fourth Quarter and Full-Year 2017 Financial Results 23
Nov 20, 2017: Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017 24
Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 25
Corporate Communications 26
Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry 26
Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO 27
Other Significant Developments 28
Jul 10, 2018: Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Brainsway Ltd, Medical Equipment, Key Facts, 2017 2
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Raises USD8.5 Million in Financing 10
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd, Key Competitors 17
Brainsway Ltd, Key Employees 18
Brainsway Ltd, Subsidiaries 19

List of Figures
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Robert Half International Inc.:企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SFS Group AG:企業の戦略・SWOT・財務分析
    SFS Group AG - Strategy, SWOT and Corporate Finance Report Summary SFS Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務分析
    Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Amgen, Inc.:企業の戦略・SWOT・財務情報
    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Econet Wireless Zimbabwe Ltd:企業の戦略・SWOT・財務分析
    Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Apollo Consolidated Ltd (AOP):企業の財務・戦略的SWOT分析
    Summary Apollo Consolidated Ltd (Apollo), formerly Apollo Life Sciences Ltd, is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, copper and nickel mineral deposits. It holds exploration permits in Western Australia …
  • Aiful Corp:企業の戦略・SWOT・財務分析
    Aiful Corp - Strategy, SWOT and Corporate Finance Report Summary Aiful Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Enauta Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析
    Summary Enauta Participacoes SA (Enauta), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company's exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambu …
  • Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • Lamellar Biomedical Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Lamellar Biomedical Ltd (Lamellar Biomedical) is a biotechnology company that develops medical products using based on mimetics of extra-alveolar lamellar bodies. The company develops products using its proprietary Lamellasome technology that are mimetics of native extra-alveolar lamellar th …
  • Safaricom Ltd:企業の戦略・SWOT・財務分析
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fuel Performance Solutions Inc (IFUE):企業の財務・戦略的SWOT分析
    Summary Fuel Performance Solutions Inc (FPS), formerly International Fuel Technology Inc is an oil and gas company that develops liquid fuel additive formulations designed to enhance the performance of liquid hydrocarbon and bio-diesel fuels. The company offers products such as diesel, gasoline, bio …
  • Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Abiogen Pharma SpA (Abiogen), a subsidiary of MDM Holding SpA, is a specialist pharmaceutical company, which develops, manufactures, and markets medicines with focus on musculo-skeletal health, and rare diseases. The company offers products in the form of oral solids, injectables, semi solid …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Hunan Corun New Energy Co Ltd (600478):電力:M&Aディール及び事業提携情報
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries, among others. It also manufactures ultra-inte …
  • Isto Biologics:医療機器:M&Aディール及び事業提携情報
    Summary Isto Biologics is an orthobiologics company which manufactures and develops biological products to treat orthopedic and spine disorders. The company offers solutions in cell therapy, bone healing and regeneration that harness cells and proteins naturally found in human biology which support …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆